BAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office

Stock News

2025/11/27

BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the proposed land reserve scope under the "Tonghe Area Land Reserve Implementation Plan." On November 27, 2025, Guanghua Pharmaceutical signed a land reserve compensation agreement with the Tonghe Subdistrict Office.

According to the agreement, the compensation for the land reserve amounts to RMB 375 million. Upon meeting the "clean land" standard and other conditions, Guanghua Pharmaceutical will receive an additional land handover incentive of approximately RMB 73.3238 million. The total compensation and incentive amount to approximately RMB 449 million.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1160975531"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1160975531\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1160975531?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-27 19:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160975531","market":"sg","top_or_hot":-1,"title":"BAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office","media":"Stock News","content":"<p>BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the proposed land reserve scope under the \"Tonghe Area Land Reserve Implementation Plan.\" On November 27, 2025, Guanghua Pharmaceutical signed a land reserve compensation agreement with the Tonghe Subdistrict Office.</p>\n<p>According to the agreement, the compensation for the land reserve amounts to RMB 375 million. Upon meeting the \"clean land\" standard and other conditions, Guanghua Pharmaceutical will receive an additional land handover incentive of approximately RMB 73.3238 million. The total compensation and incentive amount to approximately RMB 449 million.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2025-11-27 19:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the proposed land reserve scope under the \"Tonghe Area Land Reserve Implementation Plan.\" On November 27, 2025, Guanghua Pharmaceutical signed a land reserve compensation agreement with the Tonghe Subdistrict Office.</p>\n<p>According to the agreement, the compensation for the land reserve amounts to RMB 375 million. Upon meeting the \"clean land\" standard and other conditions, Guanghua Pharmaceutical will receive an additional land handover incentive of approximately RMB 73.3238 million. The total compensation and incentive amount to approximately RMB 449 million.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0028","symbol_name":"國家隊","start_time":0,"source_url":"","article_id":"1160975531","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160975531","pubTimestamp":1764242442,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600332":"白云山","BK0028":"国家队","BK1606":"中医药概念","BK1191":"制药","00874":"白云山","BK0175":"白马股","BK1515":"抗疫概念","BK0070":"员工持股","BK1574":"生物医药B类股","BK0196":"行业龙头","BK0097":"医药电商","BK0239":"医药制造","01477":"欧康维视生物-B","BK1197":"保健护理产品经销商","BK0096":"民营医院","BK1521":"挪威政府全球养老基金持仓","BK0183":"MSCI概念","BK0188":"融资融券","BK0012":"证金概念"},"translate_title":"白云山PH(00874)：光华药业与同和街道办事处签订土地储备补偿协议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600332":1,"01477":1,"00874":1},"content_text":"BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the proposed land reserve scope under the \"Tonghe Area Land Reserve Implementation Plan.\" On November 27, 2025, Guanghua Pharmaceutical signed a land reserve compensation agreement with the Tonghe Subdistrict Office.\nAccording to the agreement, the compensation for the land reserve amounts to RMB 375 million. Upon meeting the \"clean land\" standard and other conditions, Guanghua Pharmaceutical will receive an additional land handover incentive of approximately RMB 73.3238 million. The total compensation and incentive amount to approximately RMB 449 million.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}